264 related articles for article (PubMed ID: 9366522)
21. Suppression of the cell proliferation and invasion phenotypes in glioma cells by the LGI1 gene.
Kunapuli P; Chitta KS; Cowell JK
Oncogene; 2003 Jun; 22(26):3985-91. PubMed ID: 12821932
[TBL] [Abstract][Full Text] [Related]
22. The p53-independent tumoricidal activity of an adenoviral vector encoding a p27-p16 fusion tumor suppressor gene.
Patel SD; Tran AC; Ge Y; Moskalenko M; Tsui L; Banik G; Tom W; Scott M; Chen L; Van Roey M; Rivkin M; Mendez M; Gyuris J; McArthur JG
Mol Ther; 2000 Aug; 2(2):161-9. PubMed ID: 10947944
[TBL] [Abstract][Full Text] [Related]
23. Down-regulation of cathepsin B expression impairs the invasive and tumorigenic potential of human glioblastoma cells.
Mohanam S; Jasti SL; Kondraganti SR; Chandrasekar N; Lakka SS; Kin Y; Fuller GN; Yung AW; Kyritsis AP; Dinh DH; Olivero WC; Gujrati M; Ali-Osman F; Rao JS
Oncogene; 2001 Jun; 20(28):3665-73. PubMed ID: 11439329
[TBL] [Abstract][Full Text] [Related]
24. PTEN gene transfer suppresses the invasive potential of human malignant gliomas by regulating cell invasion-related molecules.
Furukawa K; Kumon Y; Harada H; Kohno S; Nagato S; Teraoka M; Fujiwara S; Nakagawa K; Hamada K; Ohnishi T
Int J Oncol; 2006 Jul; 29(1):73-81. PubMed ID: 16773187
[TBL] [Abstract][Full Text] [Related]
25. Testican 2 abrogates inhibition of membrane-type matrix metalloproteinases by other testican family proteins.
Nakada M; Miyamori H; Yamashita J; Sato H
Cancer Res; 2003 Jun; 63(12):3364-9. PubMed ID: 12810672
[TBL] [Abstract][Full Text] [Related]
26. Adenoviral vector containing wild-type p16 suppresses prostate cancer growth and prolongs survival by inducing cell senescence.
Steiner MS; Zhang Y; Farooq F; Lerner J; Wang Y; Lu Y
Cancer Gene Ther; 2000 Mar; 7(3):360-72. PubMed ID: 10766342
[TBL] [Abstract][Full Text] [Related]
27. Combination therapy of malignant glioma cells with 2-5A-antisense telomerase RNA and recombinant adenovirus p53.
Komata T; Kondo Y; Koga S; Ko SC; Chung LW; Kondo S
Gene Ther; 2000 Dec; 7(24):2071-9. PubMed ID: 11223987
[TBL] [Abstract][Full Text] [Related]
28. Microglia-derived TGF-beta as an important regulator of glioblastoma invasion--an inhibition of TGF-beta-dependent effects by shRNA against human TGF-beta type II receptor.
Wesolowska A; Kwiatkowska A; Slomnicki L; Dembinski M; Master A; Sliwa M; Franciszkiewicz K; Chouaib S; Kaminska B
Oncogene; 2008 Feb; 27(7):918-30. PubMed ID: 17684491
[TBL] [Abstract][Full Text] [Related]
29. Sublethal irradiation promotes migration and invasiveness of glioma cells: implications for radiotherapy of human glioblastoma.
Wild-Bode C; Weller M; Rimner A; Dichgans J; Wick W
Cancer Res; 2001 Mar; 61(6):2744-50. PubMed ID: 11289157
[TBL] [Abstract][Full Text] [Related]
30. Adenoviral vectors expressing fusogenic membrane glycoproteins activated via matrix metalloproteinase cleavable linkers have significant antitumor potential in the gene therapy of gliomas.
Allen C; McDonald C; Giannini C; Peng KW; Rosales G; Russell SJ; Galanis E
J Gene Med; 2004 Nov; 6(11):1216-27. PubMed ID: 15459967
[TBL] [Abstract][Full Text] [Related]
31. Selective suppression of matrix metalloproteinase-9 in human glioblastoma cells by antisense gene transfer impairs glioblastoma cell invasion.
Kondraganti S; Mohanam S; Chintala SK; Kin Y; Jasti SL; Nirmala C; Lakka SS; Adachi Y; Kyritsis AP; Ali-Osman F; Sawaya R; Fuller GN; Rao JS
Cancer Res; 2000 Dec; 60(24):6851-5. PubMed ID: 11156378
[TBL] [Abstract][Full Text] [Related]
32. Expression of Matrix Metalloproteinase-26 promotes human glioma U251 cell invasion in vitro and in vivo.
Deng Y; Li W; Li Y; Yang H; Xu H; Liang S; Zhang L; Li Y
Oncol Rep; 2010 Jan; 23(1):69-78. PubMed ID: 19956866
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of a transmembrane isoform of neural cell adhesion molecule alters the invasiveness of rat CNS-1 glioma.
Owens GC; Orr EA; DeMasters BK; Muschel RJ; Berens ME; Kruse CA
Cancer Res; 1998 May; 58(9):2020-8. PubMed ID: 9581848
[TBL] [Abstract][Full Text] [Related]
34. Brain tumor invasion model system using organotypic brain-slice culture as an alternative to in vivo model.
Jung S; Kim HW; Lee JH; Kang SS; Rhu HH; Jeong YI; Yang SY; Chung HY; Bae CS; Choi C; Shin BA; Kim KK; Ahn KY
J Cancer Res Clin Oncol; 2002 Sep; 128(9):469-76. PubMed ID: 12242510
[TBL] [Abstract][Full Text] [Related]
35. Matrilysin over-expression in MCF-7 cells enhances cellular invasiveness and pro-gelatinase activation.
Wang F; Reierstad S; Fishman DA
Cancer Lett; 2006 May; 236(2):292-301. PubMed ID: 16019136
[TBL] [Abstract][Full Text] [Related]
36. Expression of the retinoblastoma (RB) tumor suppressor gene inhibits tumor cell invasion in vitro.
Li J; Hu SX; Perng GS; Zhou Y; Xu K; Zhang C; Seigne J; Benedict WF; Xu HJ
Oncogene; 1996 Dec; 13(11):2379-86. PubMed ID: 8957079
[TBL] [Abstract][Full Text] [Related]
37. The inhibitory effect of adenovirus-mediated p16INK4a gene transfer on the proliferation of lung cancer cell line.
Lee JH; Lee CT; Yoo CG; Hong YK; Kim CM; Han SK; Shim YS; Carbone DP; Kim YW
Anticancer Res; 1998; 18(5A):3257-61. PubMed ID: 9858892
[TBL] [Abstract][Full Text] [Related]
38. Adenovirus-mediated delivery of antisense gene to urokinase-type plasminogen activator receptor suppresses glioma invasion and tumor growth.
Mohan PM; Chintala SK; Mohanam S; Gladson CL; Kim ES; Gokaslan ZL; Lakka SS; Roth JA; Fang B; Sawaya R; Kyritsis AP; Rao JS
Cancer Res; 1999 Jul; 59(14):3369-73. PubMed ID: 10416596
[TBL] [Abstract][Full Text] [Related]
39. Adenovirus-mediated expression of antisense urokinase plasminogen activator receptor and antisense cathepsin B inhibits tumor growth, invasion, and angiogenesis in gliomas.
Gondi CS; Lakka SS; Yanamandra N; Olivero WC; Dinh DH; Gujrati M; Tung CH; Weissleder R; Rao JS
Cancer Res; 2004 Jun; 64(12):4069-77. PubMed ID: 15205313
[TBL] [Abstract][Full Text] [Related]
40. Antitumoral effects of defective herpes simplex virus-mediated transfer of tissue inhibitor of metalloproteinases-2 gene in malignant glioma U87 in vitro: consequences for anti-cancer gene therapy.
Hoshi M; Harada A; Kawase T; Uyemura K; Yazaki T
Cancer Gene Ther; 2000 May; 7(5):799-805. PubMed ID: 10830727
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
